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Alzheimer’s disease (AD)-related degenerative decline is associated to the presence of
amyloid beta (Aβ) plaque lesions and neuro fibrillary tangles (NFT). However, the precise
molecular mechanisms linking Aβ deposition and neurological decline are still unclear.
Here we combine genome-wide transcriptional profiling of the insular cortex of 3xTg-
AD mice and control littermates from early through to late adulthood (2–14 months
of age), with behavioral and biochemical profiling in the same animals to identify
transcriptional determinants of functional decline specifically associated to build-up
of Aβ deposits. Differential expression analysis revealed differentially expressed genes
(DEGs) in the cortex long before observed onset of behavioral symptoms in this model.
Using behavioral and biochemical data derived from the same mice and samples, we
found that down but not up-regulated DEGs show a stronger average association with
learning performance than random background genes in control not seen in AD mice.
Conversely, these same genes were found to have a stronger association with Aβ
deposition than background genes in AD but not in control mice, thereby identifying
these genes as potential intermediaries between abnormal Aβ/NFT deposition and
functional decline. Using a complementary approach, gene ontology analysis revealed
a highly significant enrichment of learning and memory, associative, memory, and
cognitive functions only among down-regulated, but not up-regulated, DEGs. Our
results demonstrate wider transcriptional changes triggered by the abnormal deposition
of Aβ/NFT occurring well before behavioral decline and identify a distinct set of genes
specifically associated to abnormal Aβ protein deposition and cognitive decline.
Keywords: beta amyloid deposits, transcriptome, memory decline, neurodegeneration, Alzheimer’s, dementia
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INTRODUCTION
Alzheimer’s disease (AD) is a degenerative disease characterized
by progressive memory impairment and loss of other cognitive
functions for which there is no current known effective treatment.
In 2010, 46.8 million people worldwide were diagnosed with
dementia and the number of cases is expected to reach almost
74.7 million cases by 2030 (Prince, 2015), with AD accounting
for over 70% of all reported cases (Ferri et al., 2005). While AD is
more common in people over 65 years of age, with age being the
most prominent risk factor, several additional risk factors have
been identified including brain injury, smoking, and even low
social engagement (Hersi et al., 2017). However, their predictive
value is limited.
AD is characterized by the progressive loss of synaptic density
and synapse number followed by overt neuronal degeneration
involving the breakdown of neuronal maintenance and survival
mechanisms (Selkoe, 2001). Key neuropathological correlates of
AD are the presence of distinctive lesions comprised of diffuse
and neuritic plaques predominantly composed of; (i) extracellular
plaques of aggregated amyloid-beta (Aβ) protein which have
been linked to neurotoxicity and axon pruning (Bharadwaj
et al., 2009; Nikolaev et al., 2009), and (ii) intraneuronal tangles
formed by aggregates of hyper-phosphorylated neurofilament-
associated protein tau -known as tau neurofibrillary tangles
(NFT)- (Selkoe, 2001; Querfurth and LaFerla, 2010) reported
to affect microtubule stability, altering the cell’s cytoskeleton
and collapses the neuron’s transport system (Iqbal et al., 2005).
Histological evidence indicates that Aβ accumulation precedes
and drives tau aggregation (Lewis et al., 2001; Oddo et al., 2003b).
Abnormal accumulation of Aβ is the result of an imbalance
between the levels of Aβ production, aggregation and clearance
(Wang et al., 2010). Aβ clearance is mediated by proteolytic
enzymes like neprilysin (Iwata et al., 2001), chaperone molecules
such as apoE (Kim et al., 2009), lysosomal (Bendiske and
Bahr, 2003), and non-lysosomal pathways (Marambaud et al.,
2005). However, the precise identity of the wider molecular
pathways that become compromised during the gradual build-
up of abnormal Aβ deposition and NFT remain largely unknown
(Selkoe and Hardy, 2016).
The use of animal models of AD can help overcome some of
the ethical and technical limitations of studying human patients.
While acknowledging the intrinsic limitations associated to
any preclinical model, animal models of AD offer a unique
opportunity to understand the progression of this condition
as samples can be extracted from individuals at different
ages including those not yet symptomatic and in controlled
circumstances. Importantly, in addition to the experimental
advantage of a model with a much shorter lifespan, life events
can be kept largely homogeneous across individuals in a given
study. Currently more than 50 different animal models have
been generated to explore AD (Stover et al., 2015). Amongst
Abbreviations: Aβ, Beta Amyloid protein; APP, Amyloid precursor protein; AD,
Alzheimer’s Disease; CTA, Conditioned Taste Aversion test; DAT, Dopamine active
transporter; DEG, Differentially expressed genes; GO, Gene ontology; LTP/LTD,
Long term potentiation/depression; NFT, Neurofibrillary tangles; MAPT,
microtubule-associated protein tau; 3xTg-AD, Triple transgenic AD mouse model.
the AD mouse models currently available, the 3xTg-AD model
reported by Oddo et al. (2003a,b) is one of the models that
show higher similarity to the brain pathology of AD observed
in humans. This model is also one of the few models that has
been shown to develop both Aβ plaques and NFT as well as well-
known neurochemical hallmarks such as gradual dysfunction
of the cholinergic and dopaminergic systems; both believed to
contribute to the age-related cognitive decline in AD (Guzmán-
Ramos et al., 2012b; Do et al., 2014; Moreno-Castilla et al.,
2016; Selkoe and Hardy, 2016). The 3xTg-AD mouse model has
two different polymorphisms associated with AD in humans:
presenilin-1 (PSEN1), Aβ precursor protein (APP) as well as a
mutant allele of the microtubule-associated protein tau (MAPT).
These mice are viable, fertile and display no initial gross physical
abnormalities, while presenting abnormal Aβ deposition and
NFTs, with early brain lesions being observable as early as
6th month of age (Oddo et al., 2003b; Caruso et al., 2013).
The 3xTg-AD mice have been shown to display learning and
memory deficits in a wide range of learning and memory tests
including Barnes maze, Morris water maze (Oddo et al., 2006),
object recognition memory, conditioned taste aversion (CTA)
and others (Chin, 2011; Guzmán-Ramos et al., 2012b; Moreno-
Castilla et al., 2016).
Here we use the CTA learning paradigm as a simple,
robust and experimentally tractable learning model known to be
mediated by a well-defined cortical region (the insular cortex,
Guzmán-Ramos et al., 2012a; Moreno-Castilla et al., 2016;
Wu et al., 2020), to detect molecular mediators linking the
progressive build-up of Aβ aggregates with cognitive decline.
More specifically, we combine genome-wide transcriptional
profiling of the cortex of 3xTg-AD mice and control littermates
before, during and after the onset of behavioral symptoms (2–
14 months of age) with behavioral and biochemical profiling
in the exact same mice, to identify wider transcriptional
determinants of functional decline specifically associated to the
progressive build-up of Aβ deposition. Our results demonstrate
wider transcriptional changes occurring well before behavioral
decline triggered by the abnormal deposition of Aβ taking place
in this model, and identify a distinct set of genes specifically
associated to both Aβ protein build up and behavioral decline.
MATERIALS AND METHODS
Behavioral Assessment
Mice crosses to obtain 3xTg-AD homozygous (from the Jackson
Laboratory) and corresponding controls were performed as
described elsewhere (Guzmán-Ramos et al., 2012a). Only male
mice were used to maintain homogenous conditions and avoid
hormonal-driven behavioral variations affecting the learning
task readouts. Prior to tissue sample collection, animals were
tested for learning and memory performance at 2, 7, 8, 11, and
14 months of age using conditioned taste aversion (CTA) assay
as described by Moreno-Castilla et al. (2016). This behavioral
test consists of pairing a novel flavor (a single presentation of
a saccharin solution) with a gastric malaise stimulus induced
via an IP injection of lithium chloride (LiCl). After 24 h from
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the initial presentation of saccharine solution and LiCl injection,
aversion to the novel flavor was assessed by measuring the level
of consumption of a saccharin solution compared to water. An
aversion measure was calculated dividing the saccharin solution
intake by the sum of the baseline water consumption and
saccharin solution intake.
Tissue Sample Collection
After CTA memory testing, mice were euthanized by cervical
dislocation. Insular cortex was bilaterally dissected and tissue
from both hemispheres was aggregated into a single sample per
animal. Samples were taken from a total of 30 male mice, three
wild-type mice and three 3xTg-AD mutant mice at each chosen
postnatal age. Tissue samples were stored in RNA-LaterR at −80C
until further analysis.
Expression Data
PolyA-selected Illumina RNA-seq was performed on one
hemisphere of the insular cortex dissected from each mouse.
The FastQC tool was used to evaluate the quality of the data.
Trimmomatic software was employed to filter poor quality reads
and remove Illumina adapters. Transcriptome annotation was
carried out using tophat2, samtools and R software (version 3.2.2
(2015-08-14)—“Fire Safety”). Genes that displayed zero variance
across samples and those that had a cumulative RPKM value
of less than five across all samples were discarded, leaving total
of 16,894 protein coding genes. The RPKM expression data,
together with behavioral and Aβ-42 deposition data is available
in the GEO public database (accession number: GSE161904).
Differential Expression Analysis
Differential expression analyses were carried out with the edgeR
package supported in R (Robinson et al., 2010) using TMM
normalization as proposed by Robinson and Oshlack (2010) and
the exact test model (Robinson and Smyth, 2008). Differentially
expressed genes (DEGs) were identified by comparing wild type
and 3xTg-AD samples for each time point separately.
Functional Enrichment Analysis
Enrichment analyses of functional annotations of Gene Ontology
(GO) terms was performed after pooling up and down-regulated
DEGs across time points in the 3xTg-AD mouse model after
pooling. We tested for significant over-representation of specific
gene ontologies using the WEB-based Gene SeT AnaLysis
Toolkit (WebGestalt) available online (Zhang et al., 2005).
Overrepresented functional terms were identified after correcting
for multiple testing.
Aβ Deposition Quantification
Amyloid Betta (isoforms 42 and 41) deposition was quantified
using the milliplex enzyme-linked immunosorbent assay
(ELISA) platform. Quantification assays were performed twice
(2 × n = 3 animals per group of age) following manufacturer’s
guidelines with duplicate measurements per sample. We used
a highly sensitive milliplex R© MAP Kit (Cat # HNABTMAG-
68K, Millipore) with color-coded microspheres (beads) and
fluorescent dyes; through precise concentrations, the beads
simultaneously and specifically capture amyloid beta 1–40 and
1–42. A total of 25 µL of sample was introduced into a plate
containing the microspheres. After an analyte from a test sample
is captured by the bead, a biotinylated detection antibody is
introduced. The reaction mixture was then incubated with
Streptavidin-PE conjugate, the reporter molecule, to complete
the reaction on the surface of each microsphere. To acquire and
analyze data, we used a Luminex R© MAGPIX R© instrument where
each individual microsphere was identified and the result of its
bioassay was quantified.
Randomization Test
To assess the possible relationship between the DEGs in the
cortex with Aβ deposition and learning performance of each
mouse, we obtained absolute Pearson correlation coefficients
for the expression levels for each gene in all the mice across
all five developmental stages against both Aβ deposition and
aversion index. A randomization test was carried out to assess the
significance of the association between gene expression patterns
with Aβ deposition and aversion index for DEG genes. For this,
we calculated the average of the absolute correlation coefficients
between gene expression levels and either Aβ deposition or
the aversion index for all DEG genes. This mean value was
then compared to the mean value of absolute correlation
coefficients of 1,000 equally sized randomly selected samples of
background genes. Association between the expression of DEGs
and either Aβ deposition or behavioral performance was regarded
as significant if the mean absolute correlation for DEGs was
greater than the largest mean correlation value observed in the
random background gene samples (p < 0.001). All large-scale
calculations were carried out using the programming language R
and associated libraries.
RESULTS
In order to characterize the transcriptional changes that occur
in the insular cortex in response to the build-up of Aβ/NF
deposits and cognitive deterioration in the 3xTg-AD mouse
model, behavioral data and tissue samples were obtained from
three transgenic and three wild-type male mice at five time
points from two through to 14 months of age (n = 3/time
point, Figure 1A). Cognitive performance assessment was carried
out using the conditioned taste aversion (CTA) learning task
(see section “Materials and Methods”). Learned acquisition of
aversion for a novel flavor is known to be mediated by the
insular cortex and found to be severely impaired in adult 3xTg-
AD mice when compared with normal mice (Guzmán-Ramos
et al., 2012a; Moreno-Castilla et al., 2016). The time points chosen
were based on the fact that cognitive impairment in 3xTg-AD
mice has been documented in some memory tests as early as
4 months (Stover et al., 2015). Accordingly we have based our
choice on the time course previously characterized by Moreno-
Castilla et al. (2016), where learning deficits in Conditioned
taste aversion were observed only after the 8th moth of
age (Guzmán-Ramos et al., 2012b; Moreno-Castilla et al., 2016).
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FIGURE 1 | Experimental groups and expression profile clustering. (A) Samples were collected from cerebral cortex of three wild type mice and three 3xTg-AD
mutants at different time points throughout adult development (2, 7, 8, 11, and 14 months of age, indicated by gray vertical bands in the timeline). At the end a total
of 30 samples were obtained. (B) Multidimensional scaling (MDS) plot of the TMM normalized data. blue symbols represent wild type mice and red symbols were
used to denote 3xTG-AD mice. (C) BA-42 concentration in the same samples (± SEM) for both wild type (WT) and 3xTg-AD mice. (D) Learning performance in the
conditioned taste aversion task in the same mice. Each bar represents mean relative consumption (± SEM) of the aversively associated flavor relative to mean
base-line consumption of water. ∗p < 0.05, ∗∗p < 10−10.
All animals were euthanized immediately after the CTA
memory testing trial at each chosen age and the insular
cortex was bilaterally dissected for Aβ quantification and
transcriptional profiling.
Transcriptional profiling on tissue samples was carried out
using the Illumina RNA-seq platform for all 3xTg-AD and
wild type mice for each time point. After transcriptome
annotation and removal of genes with less than five reads
overall and those with no variance, gene expression levels
were compiled for a total of 16,894 protein-coding genes.
TMM normalization was applied to make sure expression
among samples is comparable. Multidimensional scale analysis
revealed two distinct clusters separating each experimental group
(Figure 1B). No sub-clustering was observed by age. This
result demonstrates that significant gene expression differences
are apparent in all time-points between 3xTg-AD and WT
samples. Quantification of beta amyloid deposition (isoform
Aβ-42) measured on the exact same samples show a statistically
significant difference between 3xTg-AD and WT samples
(Figure 1C, t = 11.9, p = 4.7 × 10−12). Taste aversion
learning performance carried out on the same mice prior to
tissue sampling also reveals a statistically significant difference
in consumption of novel flavor relative to base-line water
consumption (Figure 1D, t = 2.4, p = 0.023).
To assess gene expression differences, in the insular cortex,
between 3xTg-AD and WT we carried out a differential
expression analysis at each time point. This analysis revealed
a distinctly decreasing temporal trend in the number of genes
differentially expressed in 3xTg-AD samples relative to WT
samples between 2 and 14 months of age in the insular cortex,
with the most drastic decrease in the number of differentially
expressed genes (DEGs) between 7 and 8 months. This pattern
was consistent for both up-regulated and down-regulated genes
(Figure 2). This temporal trend contrasts with the known
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FIGURE 2 | Time course of differential gene expression in 3xTg-AD mice. (A) Bar charts showing the number of differentially expressed genes (DEGs) in the cortex
both up and down-regulated, on the vertical axis, as a function of age in months (horizontal axis). (B–F) Heatmaps and hierarchical clustering of triplicate samples
corresponding to each of the five time points studied (indicated in months). Each plot displays, on the vertical axis, the pulled set of DEGs detected across all five
ages (n = 1924), with the highest color intensity corresponding to the highest expression (z score-transformed).
symptomatic manifestation of cognitive decline in the 3xTg-AD
mouse model as behavioral decline increases as individuals
become older (Guzmán-Ramos et al., 2012b; Stover et al., 2015;
Moreno-Castilla et al., 2016). This result suggests that most
transcriptional alterations take place at early stages long before
behavioral decline become apparent in this model as measured
by CTA learning.
We then assessed the proportion of overlapping DEGs across
all time points to determine if there was a clearly distinct set of
differentially expressed genes at early or late stages of neurological
decline progression. Pairwise comparisons between DEGs at each
time point reveal that there is a highly statistically significant
proportion of overlapping genes across all age comparisons
(Figure 3). This result confirms the existence of a common
core of differential expression signature associated to the cortical
deposition of Aβ in the 3xTg-AD model. In all the subsequent
analyses we use the complete pool of all differentially expressed
genes across all developmental stages (n = 1,924), including up
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FIGURE 3 | Pairwise DEG overlap between all different ages. Each Venn diagram shown represents the overlap in DEGs between the indicated ages. The numbers
of DEGs at each stage are also indicated. Chi square tests were used to assess the significance in the observed overlap relative to chance expectations, the
corresponding p-values are indicated under each of the Venn diagrams.
(n = 829) and down (n = 1,125) regulated genes separately (listed
in Supplementary Table 1).
While the large number of DEGs observed suggest the
existence of widespread alterations in expression patterns in
3xTg-AD mice, many of these changes may not be directly
linked to the mechanisms of CTA learning decline in AD as
they could be the result of spurious collateral effects on gene
expression. In order to assess whether DEGs are specifically
associated to learning decline, we used learning performance data
based on the CTA test obtained from the exact same mice prior
to transcriptome profiling and calculated the absolute Pearson
correlation coefficients between the level of expression for each
gene against the acquired taste aversion index across all replicas
and time points. Absolute correlation coefficients were next
calculated separately for control and 3xTg-AD mice. The mean
absolute correlation coefficient for DEGs was then compared to
mean absolute correlations resulting from a thousand equally
sized random samples of background genes. As shown in
Figure 4A, the collective association between DEGs with CTA
learning performance was found to be significantly greater than
expected by chance in WT cortex, demonstrating that DEGs are
linked to cortically-mediated learning performance in normal
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FIGURE 4 | Mean association between behavioral performance and expression level of DEGs in the cortex of control and 3xTg-AD mice. Arrows in these graphs
represent the Z score of the mean absolute correlation between expression of DEGs and CTA behavioral performance relative to the correlation distribution (z
score-transformed) of 1,000 equally sized samples of random background genes. (A) Mean association between differentially expressed genes and learning
performance in the cortex of WT mice. (B) Mean association between differentially expressed genes and learning performance in the cortex of 3xTg-AD mice.
(C) Mean association between up-regulated differentially expressed genes and learning performance in the cortex of WT mice. (D) Mean association between
Up-regulated differentially expressed genes and learning performance in the cortex of 3xTg-AD mice. (E) Mean association between down-regulated differentially
expressed genes and learning performance in the cortex of WT mice. (F) Mean association between Down-regulated differentially expressed genes and learning
performance in the cortex of 3xTg-AD mice.
mice. This relationship was completely disrupted in the cortex of
3xTg-AD mice where the mean association between expression
and CTA learning performance of the same DEGs was actually
less than that observed in random gene sets (Figure 4B). This
finding strongly suggests an actual functional link between AD
pathogenesis and DEGs. However, it is unlikely that all of them
participate in the mechanistic onset of AD-related functional
decline as many of them could be the result of spurious
collateral regulatory alterations not directly linked with this
condition. We therefore examined up and down-regulated genes
separately in order to assess their relative association with CTA
learning. Down-regulated DEGs showed a much more significant
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association with CTA learning in WT mice than the whole set
of DEGs (Figure 4C). This association was again dramatically
disrupted in 3xTg-AD mice (Figure 4D). By contrast, the
collective association of up-regulated DEGs with CTA learning
was no different than that of random background genes in both
WT and 3xTg-AD mice (Figures 4E,F). Taken together, these
results show that only down-regulated differentially expressed
genes show a stronger average association with insular cortex-
mediated learning performance than random background genes
in control but not 3xTg-AD mice.
We then assessed whether the expression patterns of DEGs (up
and down-regulated) were specifically associated with amyloid
beta protein deposition in the insular cortex. To this end, we
assessed the collective association between DEGs and Aβ by
calculating the mean absolute Pearson correlation coefficient
between the level of expression for each and all DEGs across
all replicas and time points, and the deposition of Aβ (isoform
42) measured in the exact same samples (see section “Materials
and Methods”). We next compared the mean absolute correlation
between expression of DEGs and Aβ deposition with the
mean correlations resulting from a thousand equally sized
random samples of background genes. This analysis revealed
that cortical DEGs displayed significantly higher mean absolute
correlation with Aβ deposition only in 3xTg-AD but not WT
cortical samples (Figure 5A). Neither up nor down-regulated
DEGs showed a significant association with Aβ42 in WT mice
(Figures 5B,D,F). However, in 3xTg-AD mice, only down-
regulated DEGs displayed a highly significant association with
Aβ-42 deposition with up-regulated genes being no different
to random background genes (Figures 5C–E). Taken together,
these results demonstrate that normal expression of down but
not up-regulated DEGs is highly associated with CTA learning
performance and that this association is drastically disrupted in
3xTg-AD mice. Conversely, these same down-regulated DEGs
are strongly associated with cortical Aβ deposition in 3xTg-AD
mice but not WT mice strongly indicating that this set of genes
is directly involved in the molecular events linking Aβ deposition
and AD-related functional decline.
Using a complementary approach, we used gene ontology
enrichment analysis to test the association between learning and
memory related specific cellular functions and our identified set
of differentially expressed genes in 3xTg-AD mice. Specifically,
we looked for a potential enrichment of specific functional
categories among the up- and down-regulated genes using the
WEB-based Gene SeT AnaLysis Toolkit (WebGestalt) (Zhang
et al., 2005). We looked separately at the sum of all the up- and
down-regulated DEGs across all five time points analyzed. Then,
Gene Ontology Analysis (GO Analysis) was conducted in each
of the four sets of genes; namely: up- and down-regulated DEGs
(listed in Supplementary Table 1). We specifically examined any
potential over representation of functional categories generally
associated to learning and memory mechanisms (rather than
mechanisms specific for taste aversion learning) including:
Learning or Memory (GO:0007611), learning (GO:0007612),
memory (GO:0007613), cognition (GO:0050890), associative
learning (GO:0008306). As shown in Figure 6, down but not up-
regulated DEGs showed a highly significant enrichment of these
functional categories (a complete analysis of GO term enrichment
at each time point for either up or down regulated DEGs is
shown in Supplementary Table 2). Taken together these results
confirm the specific association of down but not up-regulated
DEGs in CTA learning and memory functions and support their
involvement in linking progressive Aβ deposition in AD and
learning performance deterioration.
DISCUSSION
In the present study, we conducted the RNA-seq gene expression
profiling of the insular cortex of 3xTg-AD mouse model and
performed a differential expression analysis to identify the
changes in gene expression that occur throughout adulthood
(2–14 months), both at symptomatic and pre symptomatic stages,
in this animal model. Animal models of AD have become a
widely accepted alternative to emulate human AD and offer
the opportunity to track molecular and functional alterations
associated to AD at different stages of progression of this disease.
Differential expression analysis comparing 3xTg-AD mice
with wild-type mice revealed that, in the insular cortex, the
largest proportion of gene expression changes occur at very early
adult stages (2–7 months) and way before the known onset of
learning decline in this model and that the actual number of
differentially expressed genes decreases as these mice become
older. Interestingly, 8 month of age seems to be a critical stage for
the 3xTg-AD model as it is at this time point where the number
of DEGs decreases drastically in the insular cortex and remains
around the same during the following stages. This temporal
trend contrasts with the known symptomatic manifestation of
cognitive decline in the 3xTg-AD mouse model as cognitive
decline (as measured by CTA learning) increases as individuals
become older (Guzmán-Ramos et al., 2012b; Stover et al., 2015;
Moreno-Castilla et al., 2016). While cognitive impairment in
3xTg-AD mice has been as documented in some memory tests
as early as 4 months (Stover et al., 2015), learning deficits in
conditioned taste aversion are typically observed only after the
8th month of age (Moreno-Castilla et al., 2016), Aβ plaques
and LTP/LTD alterations are detected at around 6 months
(Oddo et al., 2003a,Oddo et al., 2003b), with gliosis becoming
fairly evident at 7 months of age (Caruso et al., 2013). The
formation of NFTs, however, is not evident until 12 months of
age (Oddo et al., 2006), and it has been suggested that NFTs
could contribute to the vascular volume abnormalities observed
in the 3xTg-AD mouse model, which appear as early at 6 months
of age and are consistently present up until 18 months of
age (Do et al., 2014). For the behavioral test used in this study
(Conditioned taste aversion), our findings suggest that, during
the normal progression of this condition, a large number of
critical gene regulatory alterations are likely to take place at
rather early adult stages and long before any learning symptoms
become apparent. This in turn opens the tantalizing possibility
of identifying central (and potentially peripheral) biomarkers
capable of predicting future development of this condition at
much earlier stages.
Our finding that, in this model, the number of differentially
expressed genes follow a decreasing trend in time, as the actual
pathology aggravates, also suggests that most gene expression
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FIGURE 5 | Mean association between Aβ-42 protein deposition and expression level of DEGs in the cortex of control and 3xTg-AD mice. Arrows in these graphs
represent the Z score of the mean absolute correlation Between expression of DEGs and Ba42 deposition relative to the correlation distribution (z score transformed)
of 1,000 equally sized samples of random background genes. (A) Mean association between differentially expressed genes and Aβ-42 deposition in the cortex of
WT mice. (B) Mean association between differentially expressed genes and Aβ-42 deposition in the cortex of 3xTg-AD mice. (C) Mean association between
up-regulated differentially expressed genes and Aβ-42 deposition in the cortex of WT mice. (D) Mean association between Up-regulated differentially expressed
genes and Aβ-42 deposition in the cortex of 3xTg-AD mice. (E) Mean association between down-regulated differentially expressed genes and Aβ-42 deposition in
the cortex of WT mice. (F) Mean association between Down-regulated differentially expressed genes and Aβ-42 deposition in the cortex of 3xTg-AD mice.
changes measured in post-mortem samples obtained from AD
patients could represent a small proportion of the most critical
gene expression alterations effectively linked to the initial onset
of this condition, a circumstance that could also hold for other
neurological conditions (i.e., Parkinson’s disease, schizophrenia,
and others). In addition, it is worth noting that many of these
changes could actually follow opposing trends at different time
points, and at early asymptomatic stages. Thus for instance,
dopaminergic functions have been studied in the context of
AD-related pathology (Kar et al., 2004; Guzmán-Ramos et al.,
2012a; Puzzo and Arancio, 2013; Moreno-Castilla et al., 2016),
with key alterations including reduced secretion of dopamine,
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FIGURE 6 | Gene ontology enrichment analysis of differentially expressed
genes in the cortex of 3xTG-AD mice. Enrichments on up- and
down-regulated DEGs in cortex are shown for genes annotated to the
following functional categories associated to learning and memory
mechanisms: Learning or Memory (GO:0007611), learning (GO:0007612),
memory (GO:0007613), cognition (GO:0050890), associative learning
(GO:0008306). Bars show the probability values after Benjamini-Hochberg
correction for multiple testing in a negative logarithm scale for each of the
functional categories tested. Only cortical down-regulated genes showed a
statistically significant enrichment with these categories.
reduced expression of the dopamine receptor (mainly D2
subtypes) and lower dopamine active transporter (DAT)
expression in the hippocampus and frontal cortex (Alkondon
and Albuquerque, 2002; Palop and Mucke, 2010), along with
reduced dopamine transmission through D1 and D2 receptors
(Iqbal et al., 2013). Among the differentially expressed genes we
identify in this study, is precisely the dopamine receptor D2.
While this receptor appears normally expressed at late stages
(11th an 14th months), it was found significantly up-regulated
during the second month to then become significantly down-
regulated by the 8 month of age, suggesting a link between these
early gene regulatory disturbances and subsequent dopaminergic
dysfunctions observed in AD patients.
In this study, we combined temporal RNA-seq transcriptional
profiling of the brain cortex in 3xTg-AD mice with behavioral
and biochemical readouts obtained from the exact same animals
(i.e., learning performance in the CTA test and Aβ-42 deposition
measured in the same animals and tissue samples). As far as we
know, a combined approach of this nature in AD models has
never been attempted before. By looking at correlations between
the time-course of gene expression and either, CTA learning and
memory performance on the one hand, or Aβ deposition on
the other, we are able to identify transcriptional determinants
specifically associated with both amyloid deposition and
progressive functional decline. While conventional differential
expression profiling can identify scores of genes abnormally
regulated in this condition, a large proportion of them are likely
to be the result of spurious collateral regulatory alterations not
directly linked to underlying mechanisms of disease progression.
Indeed, we found that among all differentially expressed genes,
only down-regulated DEGs were, collectively, strongly associated
with CTA learning in control mice when compared with random
background genes, as shown by our randomization analysis. This
strong collective association was found severely disrupted in the
3xTg-AD mice. Conversely, these same genes were found to be
strongly associated with Aβ deposition only in 3xTg-AD mice,
but not controls. On the other hand, the subset of up-regulated
DEGs were no more associated to learning performance or Aβ
deposition than random background genes in both control and
3xTg-AD mice. The fact that a very specific set of genes undergoes
a distinct switch from displaying a strong association with CTA
learning in healthy mice to a strong association with gradual Aβ
deposition in 3xTg-AD mice strongly points toward these specific
genes as key mediators of the cognitive decline triggered by the
gradual Aβ imbalances taking place during AD progression.
Using a complementary approach based on gene ontology
enrichment analysis, we further tested the potential
overrepresentation of biological functions associated with
learning and memory mechanisms among either up or down-
regulated DEGs. This analysis confirmed a specific and highly
significant enrichment of learning and memory-related biological
processes exclusively among down, but not up-regulated DEGs.
Taken together, these results identify, by combining behavioral
and biochemical data with transcriptional profiling, a subset
of differentially expressed genes specifically associated with
progressive beta amyloid deposition on the one hand and CTA
learning decline on the other.
Few previous studies have looked into overall patterns of
differential expression in mouse models of AD. And usually these
have been carried out at a single time point (Reddy et al., 2004;
Mirnics et al., 2005; Unger et al., 2005; Kim k. H. et al., 2012;
Kim T.-K. et al., 2012; Castillo et al., 2017). However, changes
in the time course of expression patterns before, during and
after the onset of functional decline specifically linking Aβ/NFT
imbalances with learning decline remain poorly understood, with
only two studies recently reporting data on general temporal
changes in expression patterns in two mouse models. One study
was carried out in 3xTg-AD mice using comparative microarray
profiling of hippocampal expression patterns at 3 and 12 months
using an experimental set up aimed at identifying common
genetic mechanisms shared by aging and AD-like backgrounds
(Gatta et al., 2014). While the cited study identifies a number
of up and down-regulated hippocampal genes shared by young
3xTg-AD and normal aging mice, (suggesting the early onset of
aging-related mechanisms during AD progression), it remains
uncertain which of the observed changes are directly responsible
for the link between Aβ/NFT imbalances and functional decline
as opposed to collateral transcriptional changes not directly
involved in AD progression. A second study recently reported
was carried out on the 5XFAD mouse model (a model carrying
five mutations associated to the familial form of AD) at four
time points, two before and two after the onset of cognitive
decline in this model (Landel et al., 2014). While, compared with
other models, 5XFAD mice display AD features much earlier but
with no clear tau pathology, a consistent signature of differential
expression reveals that many of the DEGs specific to the
5XFAD model belong to neuroinflammatory processes typically
associated with plaques (Bouter et al., 2014; Landel et al., 2014).
It is worth noting that the time course of differential expression in
5XFAD mice shows an increasing rather than decreasing trend in
the number of DEGs as time progresses (Landel et al., 2014). This
increasing trend in the number of DEGs starkly contrasts with
the decreasing trend we found in the cortex of 3xTg-AD mice
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where the largest number of DEGs was observed at 2 months
of age with a gradual reduction at later stages after the onset of
functional decline in these mice. This contrast between the two
models suggests differences in the time course of gene regulatory
alterations triggered by the different transgenic backgrounds.
Our finding that only a subset of differentially expressed genes
display a direct association with both amyloid deposition and
changes in learning performance illustrate that a large proportion
of differential expression events are likely to be the result of
spurious collateral regulatory alterations not directly linked with
the underlying mechanisms of AD pathogenesis. Future studies
aligning transcriptional profiling with changes in behavioral and
biochemical parameters in 5XFAD mice, will help gain critical
insights into the molecular mechanisms specifically associated to
disease development in this preclinical model.
While current animal models offer an invaluable opportunity
to gain critical insights into such a complex pathology as AD
and neurodegeneration in general, caution is necessarily needed
when extrapolating to the human context, and further work
will be needed to properly bridge the gap between our current
understanding of this condition, based on animal models, and the
clinical settings.
In summary, our analyses of the time course of transcriptional
alterations in the 3xTg-AD mice combined with biochemical
and behavioral profiling in the same mice, reveal widespread
changes in gene expression, most of which taking place long
before the onset of functional decline in this model (as assessed
using the CTA learning paradigm), opening the possibility of
identifying key biomarkers at very early pre-symptomatic stages
of the disease. We additionally found that only down-regulated
DEGs show a specific collective association with CTA learning
performance in healthy mice and that this association is severely
disrupted in 3xTg-AD mice. Conversely, this same subset of
DEGs displays a specific, collective, association with gradual
increases in Aβ deposition in 3xTg-AD mice but not in healthy
mice, suggesting that these genes constitute a central part of the
machinery that directly links gradual imbalances in Aβ clearance
on the one hand and cognitive decline in AD.
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